LONG‐TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPDATED RESULTS FROM LOTIS‐2, THE PIVOTAL PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

Journal article

Peer reviewed

P. F Caimi, W. Z Ai, J. P. Alderuccio, K. M Ardeshna, M. Hamadani, B. Hess, B. S Kahl, J. Radford, M. Solh, A. Stathis, …

Hematological oncology, Vol.41(S2), pp.209-212

2023-06

Metrics

2 Record Views

Title: LONG‐TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPDATED RESULTS FROM LOTIS‐2, THE PIVOTAL PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA
Creators: P. F Caimi - Cleveland Clinic
W. Z Ai - UCSF Helen Diller Family Comprehensive Cancer Center
J. P. Alderuccio - Sylvester Comprehensive Cancer Center
K. M Ardeshna - University College London Hospitals NHS Foundation Trust
M. Hamadani - Medical College of Wisconsin
B. Hess - Medical University of South Carolina
B. S Kahl - Washington University in St. Louis
J. Radford - Manchester Academic Health Science Centre
M. Solh - Northside Hospital
A. Stathis - Institute of Oncology Research
P. L. Zinzani - University of Bologna
Y. Wang - Adc Therapeutics
Y. Qin - Adc Therapeutics
L. Wang - Adc Therapeutics
C. Xu - Adc Therapeutics
C. Carlo-Stella - Humanitas University
Publication Details: Hematological oncology, Vol.41(S2), pp.209-212
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031821343902976